Brian Anderson, MD

Title(s)Assistant Professor, Psychiatry
SchoolSchool of Medicine
Address1001 Potrero Avenue, #001
San Francisco CA 94110
PronounsHe/Him/His
vCardDownload vCard

    Collapse Biography 
    Collapse education and training
    San Francisco VA Medical CenterPostdoctoral Research Fellowship2018-20Advanced Neurosciences
    UCSFResidency2015-18Psychiatry
    UCSFInternship2014-15Psychiatry
    StanfordMD2008-14School of Medicine
    London School of EconomicsMSc2010-11Sociology
    University of PennsylvaniaBA2003-07Biochemistry
    Collapse awards and honors
    UCSF Department of Psychiatry2018Academic Scholarship Award
    SFGH2015Krevans Award for Patient Care
    Society for Medical Anthropology ADTSG2011Annual Student Paper Prize

    Collapse Overview 

    Collapse ORNG Applications 
    Collapse Clinical Trials
    Collapse Featured Publications
    Collapse Collaboration Interests

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. On Minimizing Risk and Harm in the Use of Psychedelics. Psychiatr Res Clin Pract. 2025; 7(1):4-8. Evans J, Aixalà M, Anderson BT, Brennan W, Bremler R, Breeksema JJ, Burback L, Calder AE, Carhart-Harris RL, Cheung K, Devenot N, Gorman I, Gren J, Hendricks PS, Holoyda B, Jacobs E, Krecké J, Kruger DJ, Luke D, Majic T, McGuire AL, Mehtani NJ, Mathai DS, Nash K, Noorani T, Palitsky R, Robinson OC, Simonsson O, Stahre E, van Elk M, Yaden DB. PMID: 40171068; PMCID: PMC11956720.
      View in: PubMed   Mentions:
    2. Psychedelic Regulation Beyond the Controlled Substances Act: A Three-Dimensional Framework for Characterizing Policy Options. Am J Psychiatry. 2025 Jan 01; 182(1):6-9. Mian MN, Dinh MT, Coker AR, Mitchell JM, Anderson BT. PMID: 39741445; PMCID: PMC11772052.
      View in: PubMed   Mentions:    Fields:    
    3. Psilocybin-assisted therapy and HIV-related shame. Sci Rep. 2024 08 02; 14(1):17919. Mehtani NJ, Johnson MO, Hendricks PS, Mitchell J, Anderson BT. PMID: 39095420; PMCID: PMC11297300.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    4. In Memoriam: Roland R. Griffiths (July 19, 1946-October 16, 2023). J Psychoactive Drugs. 2024 May 06; 1-2. Henningfield JE, Belouin SJ, Yaden DB, Urrutia J, Anderson BT, Berger A, Grob CS, Labate BC, Maier LJ, Maternowska MC, Weichold F, Magar V. PMID: 38706326.
      View in: PubMed   Mentions:    Fields:    
    5. Older adults in psychedelic-assisted therapy trials: A systematic review. J Psychopharmacol. 2024 Jan; 38(1):33-48. Bouchet L, Sager Z, Yrondi A, Nigam KB, Anderson BT, Ross S, Petridis PD, Beaussant Y. PMID: 38240068.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    6. Psychedelics in Addiction Treatment-Navigating a Sociopolitical Rift. JAMA Neurol. 2024 Jan 16. Mehtani NJ, Anderson BT, Mitchell JM. PMID: 38227310.
      View in: PubMed   Mentions:    Fields:    
    7. Misinterpretations and Omissions: A Critical Response to Goodwin and Colleagues' Commentary on Psilocybin-Assisted Therapy. Am J Psychiatry. 2024 Jan 01; 181(1):74-75. O'Donnell KC, Anderson BT, Barrett FS, Bogenschutz MP, Grob CS, Hendricks PS, Kelmendi B, Nayak SM, Nicholas CR, Paleos CA, Stauffer CS, Gukasyan N. PMID: 38161295.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    8. Psychedelic Science, Contemplative Practices, and Indigenous and Other Traditional Knowledge Systems: Towards Integrative Community-Based Approaches in Global Health. J Psychoactive Drugs. 2023 Nov-Dec; 55(5):523-538. Urrutia J, Anderson BT, Belouin SJ, Berger A, Griffiths RR, Grob CS, Henningfield JE, Labate BC, Maier LJ, Maternowska MC, Weichold F, Yaden DB, Magar V. PMID: 37747281.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    9. Psychedelic Research and Therapeutic Practices: Embracing Communities, Groups, and Traditional Knowledge. J Psychoactive Drugs. 2023 Nov-Dec; 55(5):519-522. Magar V, Urrutia J, Anderson BT. PMID: 37842876.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    10. Psychedelic therapies reconsidered: compounds, clinical indications, and cautious optimism. Neuropsychopharmacology. 2024 Jan; 49(1):96-103. Mitchell JM, Anderson BT. PMID: 37479859; PMCID: PMC10700471.
      View in: PubMed   Mentions: 8     Fields:    
    11. Commentary: Evidence-Informed Recommendation to Achieve Approximate Parity in the Allowed Number of Doses for Common Psychedelics. J Psychoactive Drugs. 2024 Apr-Jun; 56(2):206-210. Thomas KL, Jesse R, Mehtani NJ, Mitchell JM, Anderson BT. PMID: 37061961.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    12. Policy considerations that support equitable access to responsible, accountable, safe, and ethical uses of psychedelic medicines. Neuropharmacology. 2022 11 15; 219:109214. Belouin SJ, Averill LA, Henningfield JE, Xenakis SN, Donato I, Grob CS, Berger A, Magar V, Danforth AL, Anderson BT. PMID: 35973601; PMCID: PMC9536012.
      View in: PubMed   Mentions: 10     Fields:    
    13. If the Doors of Perception Were Cleansed, Would Chronic Pain be Relieved? Evaluating the Benefits and Risks of Psychedelics. J Pain. 2022 10; 23(10):1666-1679. Dworkin RH, Anderson BT, Andrews N, Edwards RR, Grob CS, Ross S, Satterthwaite TD, Strain EC. PMID: 35643270.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    14. Special considerations for evaluating psilocybin-facilitated psychotherapy in vulnerable populations. Neuropharmacology. 2022 08 15; 214:109127. Ortiz CE, Dourron HM, Sweat NW, Garcia-Romeu A, MacCarthy S, Anderson BT, Hendricks PS. PMID: 35577136.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    15. Comment and Response: (Lugo-Radillo & Cortez-Lopez, 2020) Long-Term Amelioration of OCD Symptoms in a Patient with Chronic Consumption of Psilocybin-Containing Mushrooms. J Psychoactive Drugs. 2022 Sep-Oct; 54(4):324-327. Fitzpatrick CM, Anderson BT, Agin-Liebes G, Guydish J. PMID: 35083957.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimals
    16. The Potential of Psychedelics for End of Life and Palliative Care. Curr Top Behav Neurosci. 2022; 56:169-184. Yaden DB, Nayak SM, Gukasyan N, Anderson BT, Griffiths RR. PMID: 34958455.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    17. Psilocybin-Assisted Group Therapy and Attachment: Observed Reduction in Attachment Anxiety and Influences of Attachment Insecurity on the Psilocybin Experience. ACS Pharmacol Transl Sci. 2021 Apr 09; 4(2):526-532. Stauffer CS, Anderson BT, Ortigo KM, Woolley J. PMID: 33860182; PMCID: PMC8033604.
      View in: PubMed   Mentions: 25  
    18. Psychedelic medicine: safety and ethical concerns. Lancet Psychiatry. 2020 10; 7(10):829-830. Anderson BT, Danforth AL, Grob CS. PMID: 32949507.
      View in: PubMed   Mentions: 27     Fields:    
    19. Psilocybin-assisted group therapy for demoralized older long-term AIDS survivor men: An open-label safety and feasibility pilot study. EClinicalMedicine. 2020 Oct; 27:100538. Anderson BT, Danforth A, Daroff PR, Stauffer C, Ekman E, Agin-Liebes G, Trope A, Boden MT, Dilley PJ, Mitchell J, Woolley J. PMID: 33150319; PMCID: PMC7599297.
      View in: PubMed   Mentions: 69  
    20. Psychedelic-Assisted Group Therapy: A Systematic Review. J Psychoactive Drugs. 2019 Apr-Jun; 51(2):174-188. Trope A, Anderson BT, Hooker AR, Glick G, Stauffer C, Woolley JD. PMID: 30950777; PMCID: PMC6650145.
      View in: PubMed   Mentions: 27     Fields:    Translation:Humans
    21. Violence, addiction, recovery: An anthropological study of Mexico's anexos. Transcult Psychiatry. 2016 08; 53(4):445-64. Garcia A, Anderson B. PMID: 27535824; PMCID: PMC5531188.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    22. 'Spirituality' and 'cultural adaptation' in a Latino mutual aid group for substance misuse and mental health. BJPsych Bull. 2015 Aug; 39(4):191-5. Anderson BT, Garcia A. PMID: 26755953; PMCID: PMC4706138.
      View in: PubMed   Mentions: 3  
    23. The Therapeutic Use of Ayahuasca (Labate & Cavnar, Eds). Healing with Yagé: An Interview with Taita Juan Bautista Agreda Chindoy. 2014; 197-215. Anderson, Brian T., Beatriz Caiuby Labate, and Celina M. De Leon .
    24. Statement on ayahuasca. Int J Drug Policy. 2012 May; 23(3):173-5. Anderson BT, Labate BC, Meyer M, Tupper KW, Barbosa PC, Grob CS, Dawson A, McKenna D. PMID: 22459485.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansAnimals
    25. Ayahuasca as antidepressant? Psychedelics and styles of reasoning in psychiatry. Anthropology of Consciousness. 2012; 23(1):44-59. Anderson, Brian T. View Publication.
    26. Ayahuasca, ritual and religion in Brazil (Labate & MacRae, Eds). The treatment and handling of substance dependence with ayahuasca: Reflections on current and future research. 2010; 205-227. Labate, B. C., Santos, R. G., Anderson, B., Mercante, M., & Barbosa, P. C. R.
    27. Enhanced sensitivity of the MRL/MpJ mouse to the neuroplastic and behavioral effects of chronic antidepressant treatments. Neuropsychopharmacology. 2009 Jun; 34(7):1764-73. Balu DT, Hodes GE, Anderson BT, Lucki I. PMID: 19177066; PMCID: PMC2680932.
      View in: PubMed   Mentions: 29     Fields:    
    28. Psychedelic Psychotherapy: The Ethics of Medicine for the Soul. Penn Bioethics Journal. 2006; 2(1). Anderson, Brian .
    Brian's Networks
    Concepts (69)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (11)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (59)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCSF Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).

    We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use. This site is running Profiles RNS version UCSF-v3.1.0-15-g9ae42700 on PROFILES-PWEB03.

    Copyright © The Regents of the University of California.